January 1, 2025Medical Research Archives

Anemia of the Chronic Kidney Disease: A Comparision Between Oral and Intravenous Iron Therapy Combined with Erythropoietin

View Full Paper

Ask AI

Bookmark

Intravenous iron therapy resulted in a greater increase in hemoglobin compared to oral iron therapy, indicating better efficacy in treating anemia.
Group B, receiving intravenous iron dextran with erythropoietin, showed a mean transferrin saturation of 39.80%, significantly higher than 26.96% in Group A.
Assessment of both treatment methods over six months highlights the superiority of intravenous iron in managing anemia in chronic kidney disease patients.
This research supports the use of intravenous iron therapy in clinical practice, as it may lead to improved patient outcomes compared to oral supplementation.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This trial demonstrates that intravenous iron therapy significantly improves transferrin saturation in chronic kidney disease patients, suggesting a better option than oral iron.

Cite This Study

Memon et al. (2025) studied this question.

synapsesocial.com/papers/68af2979cf1dd9ea359e3466 https://doi.org/10.18103/mra.v13i6.6722

View Full Paper

Ask AI

Bookmark

Implication

This trial demonstrates that intravenous iron therapy significantly improves transferrin saturation in chronic kidney disease patients, suggesting a better option than oral iron.

Anemia of the Chronic Kidney Disease: A Comparision Between Oral and Intravenous Iron Therapy Combined with Erythropoietin

Key Points

Discussion

Implication

Cite This Study

Anemia of the Chronic Kidney Disease: A Comparision Between Oral and Intravenous Iron Therapy Combined with Erythropoietin

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider